These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22114194)

  • 1. Estrogen receptor β and 17β-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer.
    Muthusamy S; Andersson S; Kim HJ; Butler R; Waage L; Bergerheim U; Gustafsson JÅ
    Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20090-4. PubMed ID: 22114194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.
    Guerini V; Sau D; Scaccianoce E; Rusmini P; Ciana P; Maggi A; Martini PG; Katzenellenbogen BS; Martini L; Motta M; Poletti A
    Cancer Res; 2005 Jun; 65(12):5445-53. PubMed ID: 15958594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.
    Oliveira AG; Coelho PH; Guedes FD; Mahecha GA; Hess RA; Oliveira CA
    Steroids; 2007 Dec; 72(14):914-22. PubMed ID: 17854852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol.
    Dondi D; Piccolella M; Biserni A; Della Torre S; Ramachandran B; Locatelli A; Rusmini P; Sau D; Caruso D; Maggi A; Ciana P; Poletti A
    Endocr Relat Cancer; 2010 Sep; 17(3):731-42. PubMed ID: 20562232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus.
    Lund TD; Hinds LR; Handa RJ
    J Neurosci; 2006 Feb; 26(5):1448-56. PubMed ID: 16452668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
    Chen J; Wang WQ; Lin SX
    J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells.
    Piccolella M; Crippa V; Messi E; Tetel MJ; Poletti A
    Pharmacol Res; 2014 Jan; 79():13-20. PubMed ID: 24184124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro chronic administration of ERbeta selective ligands and prostate cancer cell growth: hypotheses on the selective role of 3beta-adiol in AR-positive RV1 cells.
    Colciago A; Ruscica M; Mornati O; Piccolella M; Montagnani-Marelli M; Eberini I; Festuccia C; Magni P; Motta M; Negri-Cesi P
    Biomed Res Int; 2014; 2014():801473. PubMed ID: 24877132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydrotestosterone synthesis pathways from inactive androgen 5α-androstane-3β,17β-diol in prostate cancer cells: Inhibition of intratumoural 3β-hydroxysteroid dehydrogenase activities by abiraterone.
    Ando T; Nishiyama T; Takizawa I; Ishizaki F; Miyashiro Y; Takeda K; Hara N; Tomita Y
    Sci Rep; 2016 Aug; 6():32198. PubMed ID: 27561382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor-beta mediates dihydrotestosterone-induced stimulation of the arginine vasopressin promoter in neuronal cells.
    Pak TR; Chung WC; Hinds LR; Handa RJ
    Endocrinology; 2007 Jul; 148(7):3371-82. PubMed ID: 17412808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor beta dependent attenuation of cytokine-induced cyclooxygenase-2 by androgens in human brain vascular smooth muscle cells and rat mesenteric arteries.
    Zuloaga KL; O'Connor DT; Handa RJ; Gonzales RJ
    Steroids; 2012 Jul; 77(8-9):835-44. PubMed ID: 22542504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease.
    Bauman DR; Steckelbroeck S; Williams MV; Peehl DM; Penning TM
    Mol Endocrinol; 2006 Feb; 20(2):444-58. PubMed ID: 16179381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The androgen metabolite, 5α-androstane-3β,17β-diol (3β-diol), activates the oxytocin promoter through an estrogen receptor-β pathway.
    Hiroi R; Lacagnina AF; Hinds LR; Carbone DG; Uht RM; Handa RJ
    Endocrinology; 2013 May; 154(5):1802-12. PubMed ID: 23515287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer.
    Dey P; Ström A; Gustafsson JÅ
    Oncogene; 2014 Aug; 33(33):4213-25. PubMed ID: 24077289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
    He D; Falany CN
    Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells.
    Pak TR; Chung WC; Lund TD; Hinds LR; Clay CM; Handa RJ
    Endocrinology; 2005 Jan; 146(1):147-55. PubMed ID: 15471969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
    Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
    Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partitioning of 5alpha-dihydrotestosterone and 5alpha-androstane-3alpha, 17beta-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation.
    Nunlist EH; Dozmorov I; Tang Y; Cowan R; Centola M; Lin HK
    J Steroid Biochem Mol Biol; 2004 Jul; 91(3):157-70. PubMed ID: 15276623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of AKR1C1/ERβ induces apoptosis by downregulation of c-FLIP in prostate cancer cells: A prospective therapeutic opportunity.
    Yun H; Xie J; Olumi AF; Ghosh R; Kumar AP
    Oncotarget; 2015 May; 6(13):11600-13. PubMed ID: 25816367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.